Key result
Charcoal hemoperfusion efficiently removed adriamycin in preliminary experiments, but showed little utility for methotrexate removal without a highly specific sorbent.
Why the study?
Does charcoal hemoperfusion efficiently remove cancer chemotherapeutic drugs to reduce toxicity?
Population
In vitro and in vivo models for cancer chemotherapy drug removal
Design
Preclinical
Authors
Loading...
Supports targeted hemoperfusion research for adriamycin; leaves open methotrexate detoxification without specific sorbents.
Does charcoal hemoperfusion efficiently remove cancer chemotherapeutic drugs to reduce toxicity?
Charcoal hemoperfusion shows promise for removing adriamycin and daunorubicin to reduce toxicity, but lacks utility for methotrexate without a specific sorbent.
Winchester et al. (1980) studied Cancer chemotherapy toxicity. Charcoal hemoperfusion was evaluated on Chemotherapeutic drug removal. Charcoal hemoperfusion efficiently removed adriamycin in preliminary experiments, but showed little utility for methotrexate removal without a highly specific sorbent.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: